Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × Inositol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 30 Insulin Resistance 5 Infertility 5 Hyperandrogenism 3 Anovulation 3 Pre-Eclampsia 2 Metabolic Syndrome 2 Infertility, Female 2 Glucose Intolerance 2 Diabetes, Gestational 2 Carcinoma, Non-Small-Cell Lung 2 Weight Loss 1 Thyroid Nodule 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Premature Birth 1 Precancerous Conditions 1 Oligomenorrhea 1 Lung Neoplasms 1 Inflammation 1 Colonic Neoplasms 1 Amenorrhea 1

Interventions

Omeprazole 3 Exercise 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Resistance Training 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Etanercept 2 Colchicine 2 Ascorbic Acid 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dolutegravir 1 dapagliflozin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Sulindac 1 Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡